[1]
2021. Hook effect and serum KL-6 in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD). International Journal of Integrated Health Sciences. 9, 2 (Oct. 2021), 66–72. DOI:https://doi.org/10.15850/ijihs.v9n2.2488.